...
首页> 外文期刊>Journal of drugs in dermatology: JDD >Stasis dermatitis as a complication of amlodipine therapy.
【24h】

Stasis dermatitis as a complication of amlodipine therapy.

机译:停滞性皮炎是氨氯地平治疗的并发症。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Lower leg edema is a common side effect of amlodipine therapy, but is often unrecognized as a contributor to stasis dermatitis. OBJECTIVE: To determine whether amlodipine therapy is more common among patients with stasis dermatitis than age-matched controls. METHODS: In this retrospective chart review study, the medication lists of all subjects with stasis dermatitis from a single practice site over the past 2 years were compared to alphabetically consecutive charts of patients with basal cell carcinoma to determine the relative usage of amlodipine. RESULTS: Patients with stasis dermatitis (n=43) are more likely to take amlodipine than are basal cell carcinoma patients (n=117) of similar age (19% vs. 5%, P<.02), even when controlled for the use of any antihypertensive medications (25% vs. 10%, P=.05). CONCLUSION: Amlodipine therapy is associated with stasis dermatitis and discontinuing amlodipine should be considered when stasis dermatitis is diagnosed.
机译:背景:小腿水肿是氨氯地平治疗的常见副作用,但通常未被认为是淤滞性皮炎的病因。目的:确定氨氯地平治疗在瘀滞性皮炎患者中是否比年龄相称的对照组更普遍。方法:在这项回顾性图表审查研究中,将过去2年中来自单个执业地点的所有淤滞性皮炎受试者的药物清单与基底细胞癌患者的字母顺序图表进行比较,以确定氨氯地平的相对用法。结果:与年龄相仿的基底细胞癌患者(n = 117)相比,停滞性皮炎患者(n = 43)更可能接受氨氯地平(即使将其控制在19%vs. 5%,P <.02)。使用任何降压药(25%比10%,P = .05)。结论:氨氯地平治疗与淤滞性皮炎有关,诊断为淤滞性皮炎时应考虑停用氨氯地平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号